News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Kirk Hevener, PharmD, PhD

Advertisement

Articles by Kirk Hevener, PharmD, PhD

Study Shows Sulfonamide Antibacterials Capable of Reversing Azole Resistance in Candida albicans

ByKirk Hevener, PharmD, PhD
June 28th 2018

Preliminary studies provide convincing evidence for the synergistic use of sulfonamide agents with azole antifungals.

Advertisement

Latest Updated Articles

  • Study Shows Sulfonamide Antibacterials Capable of Reversing Azole Resistance in Candida albicans
    Study Shows Sulfonamide Antibacterials Capable of Reversing Azole Resistance in Candida albicans

    Published: June 28th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus

2

Measles Update: February 6, 2026

3

Antibiotics Deconstructed: IV Fosfomycin

4

PASTEUR Act Reintroduced in Congress

5

HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us